Mode
Text Size
Log in / Sign up

TIM4 restoration enhances hepatocyte clearance and limits stellate cell activation in MASH modelsSpecific liver cell signals may influence MASH disease progression

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that TIM4 restoration may improve hepatocyte clearance and limit fibrosis in MASH models, but human data is lacking.

This mini review synthesizes preclinical evidence regarding the roles of TIM4, TREM2, and MerTK signaling in metabolic dysfunction-associated steatohepatitis (MASH). The review focuses on how these specific receptors influence macrophage efferocytosis and subsequent hepatic inflammation and fibrosis in experimental models.

Key findings indicate that TIM4 restoration enhances the removal of apoptotic hepatocytes and promotes interleukin-10 production, which limits hepatic stellate cell activation. Conversely, the review notes that TREM2 inflammatory cleavage compromises efferocytosis and sustains liver inflammation. MerTK signaling is associated with promoting transforming growth factor beta1 (TGF-beta1) production and fibrogenic stellate cell responses.

The authors highlight significant limitations, including a lack of human evidence and the fact that the distinction between experimental disease progression and human fibrosis-stage evidence is not fully established. Furthermore, it remains unresolved whether efferocytosis can be preserved while pro-fibrotic signaling is restrained. These findings suggest that cell clearance and receptor signaling are distinct determinants of disease progression, but further research is required to translate these mechanisms to clinical practice.

Living with a fatty liver disease, known as MASH, can lead to serious liver inflammation and scarring over time. Scientists are looking closely at how the body clears out dying cells to keep the liver healthy. This process is called efferocytosis. When this cleanup fails, it can trigger a cycle of inflammation and permanent tissue damage.

Researchers reviewed experimental models to see how three specific receptors—TIM4, TREM2, and MerTK—impact this process. They found that restoring TIM4 helps clear dead cells and produces a protective substance called interleukin-10, which limits scarring. In contrast, a specific change in the TREM2 receptor can hurt the cleanup process and keep inflammation active. They also noted that MerTK signaling can lead to more scarring.

It is important to note that these findings come from experimental models, not from human patients. Because of this, we do not yet know if these specific signals behave the same way in people with MASH. Scientists still need to figure out how to keep the healthy cell-clearing process active while stopping the signals that cause scarring.

What this means for you:
Specific cell receptors like TIM4 and TREM2 play different roles in liver inflammation and scarring.

Common questions

What is MASH?

MASH stands for metabolic dysfunction-associated steatohepatitis. It is a condition where the liver becomes inflamed and develops fat, which can lead to scarring over time. This research looks at how specific cell signals affect how the liver handles this inflammation and the resulting tissue damage.

How do these receptors affect the liver?

The study found that restoring TIM4 helps clear dead cells and limits scarring. However, a specific change in the TREM2 receptor can hurt the cell-clearing process and keep inflammation active. Additionally, MerTK signaling was linked to more scarring in the liver.

Can these findings be used to treat people today?

Not yet. These results come from experimental models, not from human patients. There is currently a gap in human evidence, and researchers must still determine if these findings translate to human medicine before they can be used as a basis for treatment.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedNov 2026
View Original Abstract ↓
Apoptotic hepatocytes accumulate in metabolic dysfunction-associated steatohepatitis (MASH), where impaired macrophage efferocytosis can prolong inflammatory injury. Restoring their clearance offers a potential therapeutic approach, although the receptors involved also engage signaling pathways that influence fibrosis. In experimental MASH, restoration of T cell immunoglobulin and mucin domain containing 4 (TIM4) enhances apoptotic hepatocyte removal and promotes interleukin-10 production, thereby limiting hepatic stellate cell activation. Inflammatory cleavage of triggering receptor expressed on myeloid cells 2 (TREM2) compromises efferocytosis and sustains liver inflammation. Mer tyrosine kinase (MerTK) signaling can promote transforming growth factor β1 (TGF-β1) production and fibrogenic stellate cell responses. These findings highlight the need to evaluate cell clearance and receptor signaling as related but distinct determinants of disease progression. This mini review compares the evidence for TIM4, TREM2, and MerTK in MASH, with attention to macrophage heterogeneity and the distinction between experimental disease progression and human fibrosis-stage evidence. Comparisons with atherosclerosis illustrate how tissue context may alter the consequences of receptor targeting. We discuss strategies to restore TIM4 function and protect TREM2 from cleavage, alongside gaps in human evidence. Whether effective efferocytosis can be preserved while profibrotic signaling is restrained remains unresolved and requires direct testing to guide selective immune interventions in MASH.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.